Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Baesi, Kazem ^a   Moallemi, Samaneh ^a   Farrokhi, Molood ^a   Alinaghi, Seyed Ahmad Seyed ^a   Truong, Hong Ha M ^b,c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GLADSTONE INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFGHANISTAN; DATA ANALYSIS; DISEASE TRANSMISSION; DRUG TRAFFIC; DRUG USE; ENVELOPE GENE; GAG GENE; GENE; GENE SEQUENCE; GENOME; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMIGRATION; IRAN; NEIGHBOR JOINING METHOD; NONHUMAN; NUCLEOTIDE SEQUENCE; PARSIMONY ANALYSIS; PHYLOGENY; PREVALENCE; REVIEW; SEQUENCE ANALYSIS; SEQUENCE DATABASE; STRUCTURAL GENE; UNINDEXED SEQUENCE; VIRUS CLASSIFICATION; VIRUS STRAIN; CLASSIFICATION; COMPLICATION; ETHNOLOGY; FEMALE; GENETICS; HEMOPHILIA A; HIV INFECTIONS; HUMAN; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR GENETICS; NUCLEIC ACID DATABASE; SUBSTANCE ABUSE; TRANSMISSION; VIROLOGY; VIRUS GENOME;

HUMAN IMMUNODEFICIENCY VIRUS 1;

AFGHANISTAN; DATABASES, NUCLEIC ACID; FEMALE; GENES, ENV; GENES, GAG; GENES, POL; GENOME, VIRAL; HEMOPHILIA A; HIV INFECTIONS; HIV-1; HUMANS; IRAN; MALE; MOLECULAR EPIDEMIOLOGY; MOLECULAR SEQUENCE DATA; PHYLOGENY; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 84906971488     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105098     Document Type: Review

References (22)

1. Baesi K, Ravanshad M, Ghanbarisafari M, Saberfar E, Seyedalinaghi S, et al. (2014) Antiretroviral drug resistance among antiretroviral-naïve and treatment experienced patients infected with HIV in Iran. J Med Virol. 86(7):1093-1098.
2. Hu DJ, Dondero TJ, Rayfield MA, George JR, Schochetman G, et al. (1996) The emerging genetic diversity of HIV. The importance of global surveillance for diagnostics, research, and prevention. JAMA. 275(3):210-216.
3. Lessells RJ, Katzenstein DK, de Oliveira T (2012) Are subtype differences important in HIV drug resistance? Curr Opin Virol. 2(5):636-643.
4. Luft LM, Gill MJ, Church DL (2011) HIV-1 viral diversity and its implications for viral load testing: review of current platforms. Int J Infect Dis. 15(10):e661-670.
5. Wainberg MA, Brenner BG (2012) The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs. Mol Biol Int. 2012:256982.
6. Jahanbakhsh F, Ibe S, Hattori J, Manavari SH, Matsuda M, et al. (2013) Molecular Epidemiology of HIV Type 1 Infection in Iran: Genomic Evidence of CRF35-AD Predominance and CRF01-AE Infection Among Individuals Associated with Injection Drug Use. AIDS Res Hum Retroviruses. 29(1):198-203.
7. National AIDS Committee Secretariat, Ministry of Health and Medical Education (2013) Islamic Republic of Iran AIDS Progress Report: on Monitoring of the United Nations General Assembly Special Session on HIV and AIDS.
8. Jahanbakhsh F, Hattori J, Matsuda M, Ibe S, Monavari SH, et al. (2013) Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011. PLoS One. 8(4):e61864.
9. Mir-Nasseri MM, Mohammadkhani A, Tavakkoli H, Ansari E, Poustchi H (2011) Incarceration is a major risk factor for blood-borne infection among intravenous drug users. Hepat Monthly. 11(1):19-22.
10. Baesi K, Ravanshad M, Hosseini SY, Haji A A M, Shahzamani K (2010) Phylogenetic analysis of HIV-1 pol gene (RT sequences) among Iranian HIV infected patients. Sci J Iran Blood Transfus Org. 7(2):94-100.
11. Naderi HR, Tagliamonte M, Tornesello ML, Ciccozzi M, Rezza G, et al. (2006) Molecular and phylogenetic analysis of HIV-1 variants circulating among injecting drug users in Mashhad-Iran. Infect Agent Cancer. 1:4.
12. Sarrami-Forooshani R, Das SR, Sabahi F, Adeli A, Esmaeili R, et al. (2006) Molecular analysis and phylogenetic characterization of HIV in Iran. J Med Virol. 78(7):853-863.
13. Tagliamonte M, Naderi HR, Tornesello ML, Farid R, Buonaguro FM, et al. (2007) HIV type 1 subtype A epidemic in injecting drug user (IDU) communities in Iran. AIDS Res Hum Retroviruses. 23(12):1569-1574.
14. Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, et al. (2010) Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients. AIDS. 24:S85-S91.
15. Mousavi SM, Hamkar R, Gouya MM, Safaie A, Zahraei SM, et al. (2010) Surveillance of HIV drug resistance transmission in Iran: experience gained from a pilot study. Arch Virol. 155(3):329-334.
16. Soheilli ZS, Ataiee Z, Tootian S, Zadsar M, Amini S, et al. (2009) Presence of HIV-1 CRF35-AD in Iran. AIDS Res Hum Retroviruses. 25(1):123-124.
17. Kurle S, Tripathy S, Jadhav S, Agnihotri K, Paranjape R (2004) Full-length gag sequences of HIV type 1 subtype C recent seroconverters from Pune, India. AIDS Res Hum Retroviruses. 20(10):1113-1118.
18. Lynch RM, Shen T, Gnanakaran S, Derdeyn CA (2009) Appreciating HIV type 1 diversity: subtype differences in Env. AIDS Res Hum Retroviruses. 25(3):237-248.
19. Tongo M, Martin DP, Zembe L, Mpoudi-Ngole E, Williamson C, et al. (2013) Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic. Virology J. 10:29.
20. Castro-Nallar E, Perez-Losada M, Burton GF, Crandall KA (2012) The evolution of HIV: Inferences using phylogenetics. Mol Phylogenet Evol. 62(2):777-792.
21. Sanders-Buell E, Saad MD, Abed AM, Bose M, Todd CS, et al. (2007) A nascent HIV type 1 epidemic among injecting drug users in Kabul, Afghanistan is dominated by complex AD recombinant strain, CRF35-AD. AIDS Res Hum Retroviruses. 23(6):834-839.
22. Sanders-Buell E, Bose M, Nasir A, Todd CS, Stanekzai MR, et al. (2010) Distinct circulating recombinant HIV-1 strains among injection drug users and sex workers in Afghanistan. AIDS Res Hum Retroviruses. 26(5):605-608.